As regional governments confront soaring cardiometabolic disease costs, broader subsidization is expected, advancing the glucagon-like peptide-1 (GLP-1) agonists market toward leadership status in Asia-Pacific by the early 2030s
Lower levels also cue the body to store more fat, potentially contributing to weight regain
It is also rich in prebiotic fiber, which supports a healthy gut environment
It is one of the first inflammatory signals released when the immune system perceives a threat, and in psoriasis, it acts as a master switch that amplifies virtually every other inflammatory pathway involved
Our semaglutide plateau guide covers the most common causes and solutions
In summary, GLP-1 medications are a pivotal advancement, reinforcing preventative health and the food-as-medicine movement